Related Experiment Video
Updated: Jan 6, 2026
Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
A Pharmacological Perspective on Targeting the Voltage-Gated Calcium Channel Subunit α2δ(1-2) to Mitigate Traumatic
Jijo Stebin Justus1, Marcelo S Rodolphi2, Bruna Valdameri2
1Laboratory of Neurotrauma and Biomarkers, Department of Biochemistry, ICBS, Federal University of Rio Grande do Sul - UFRGS, Porto Alegre, RS, Brazil. jijo.stebin@ufrgs.br.
Abstract:
Traumatic brain injury (TBI) is a significant global public health issue, affecting millions annually. Excessive calcium influx in neurons and astrocytes triggers a cascade of neurotoxic events, including mitochondrial dysfunction, increased production of reactive oxygen species, and hypometabolism, all of which contribute to impaired neurological function. Following TBI, alterations in presynaptic voltage-gated calcium channels (VGCCs) and the formation of plasma membrane pores facilitate Ca2+ influx, membrane depolarization, and an increased vesicular release of glutamate and Ca2+ into the synaptic cleft. This leads to the overactivation of NMDA receptors and the propagation of neurotoxic Ca2+ signals to neighboring neurons, further spreading neurobiochemical disruptions. Given this, blocking Ca2+ influx may mitigate excitotoxicity, and mitochondrial alterations caused by TBI. Among the pathways involved in Ca2+ cytotoxicity, the alpha-2-delta (α2δ(1-2)) subunit of VGCCs, located at the presynaptic terminal, remains the least explored. In this review, we briefly examine the pathophysiological hallmarks of TBI and their connection to Ca2+ dysregulation, while exploring the distribution of VGCC subtypes in the brain. Additionally, we highlight pregabalin, an analog of gabapentin and a selective antagonist of the α2δ(1-2) subunit, as a promising therapeutic strategy to counteract Ca2+-induced neurotoxicity following TBI.
Insights
Traumatic brain injury (TBI) causes neurotoxicity via excessive calcium (Ca2+) influx. Blocking the alpha-2-delta (α2δ) subunit of voltage-gated calcium channels with pregabalin may offer a novel therapeutic approach for TBI.
Area of Science:
- Neuroscience
- Pharmacology
- Cellular Biology
Background:
- Traumatic brain injury (TBI) is a major global health concern with millions affected annually.
- Excessive calcium (Ca2+) influx in neurons and astrocytes initiates neurotoxic cascades, including mitochondrial dysfunction and increased reactive oxygen species, impairing neurological function.
- TBI-induced alterations in presynaptic voltage-gated calcium channels (VGCCs) and plasma membrane pores exacerbate Ca2+ influx, leading to excitotoxicity and widespread neurobiochemical disruptions.
Purpose of the Study:
- To review the pathophysiology of TBI and its link to calcium dysregulation.
- To explore the distribution of VGCC subtypes in the brain.
- To highlight pregabalin as a potential therapeutic agent targeting the α2δ subunit of VGCCs for TBI.
Main Methods:
- Literature review examining TBI pathophysiology and calcium dysregulation.
- Analysis of the role of VGCC subtypes in TBI-induced neurotoxicity.
- Discussion of pregabalin's mechanism as an α2δ subunit antagonist.
Main Results:
- Excessive Ca2+ influx is a key mechanism in TBI-related neurotoxicity.
- The α2δ subunit of VGCCs is implicated in Ca2+ cytotoxicity following TBI.
- Pregabalin, a selective α2δ antagonist, shows promise in mitigating TBI-induced neurotoxicity.
Conclusions:
- Targeting Ca2+ influx, particularly via the α2δ subunit of VGCCs, represents a viable therapeutic strategy for TBI.
- Pregabalin's antagonism of the α2δ subunit offers a promising avenue for counteracting TBI-induced excitotoxicity and neurodegeneration.
Related Concept Videos
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:19Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
01:26Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...